Sacubitril/Valsartan Outperforms ACEI/ARB Therapy in Kidney Recovery for Thrombotic Microangiopathy: JAMA Medha Baranwal17 Nov 2024 9:00 PM ISTChina: A recent cohort study has suggested that sacubitril/valsartan may offer superior kidney function benefits for patients with thrombotic...
Fluticasone propionate aerosol combined with ACEI/ARB reduces proteinuria in Immunoglobulin A nephropathy Aditi1 Aug 2023 8:00 PM ISTChina: According to a study published in BMC Nephrology, researchers have concluded that Fluticasone propionate aerosol combined with...
RAS inhibitors fail to improve outcomes in patients hospitalized with severe COVID-19: JAMA Medha Baranwal14 April 2023 8:00 PM ISTUSA: Initiating a renin-angiotensin system (RAS) inhibitor as a treatment for COVID-19 does not improve and likely worsens clinical outcomes in...
Angioedema risk not greater among new users of ARNI compared to users of ACE Inhibitors, ARBs Medha Baranwal27 Jan 2023 10:45 AM ISTThe study supports starting with sacubitril/valsartan, not switching to it in heart failure patients. USA: An increased risk of angioedema was...
Does Telmisartan improve clinical outcomes in people with COVID-19? CLARITY Trial reports data on Indian Patients Meghna A Singhania22 Nov 2022 9:00 AM ISTNew Delhi: Can angiotensin receptor blockers disrupting the renin-angiotensin-system, help in improving COVID-19 outcomes?The answer seems to be 'no'...
Angiotensin receptor blockers reduce dementia progression in hypertensive patients: AHA Jacinthlyn Sylvia9 July 2022 9:45 AM ISTChina: A new study published in the journal Hypertension showed that angiotensin receptor blockers were related to a decreased risk of dementia...
Combining ARBs, CCBs and Diuretics in controlling Resistant Hypertension in CV patients: Review Dr. Prem Aggarwal12 Nov 2021 12:57 PM ISTA significant increase in resistant hypertension (RH) has been documented in the last decade, with epidemiological data suggesting that the rise has...
Understanding ARBs: The dilemma of choice Dr S. N. Narasingan5 Oct 2021 1:00 PM ISTThis Webinar talks about the role of ARBs in managing hypertension
High dose Telmisartan may help reduce proteinuria in CKD Patients: Study Dr Kartikeya Kohli16 Feb 2021 6:55 PM ISTRenoprotective therapy, including inhibition of the renin-angiotensin system (RAS), in patients with chronic kidney disease (CKD) is important to...
Candesartan improves cognition independent of its BP-lowering effect: JAMA Medha Baranwal12 Aug 2020 5:51 PM ISTAtlanta, Georgia: One-year treatment with antihypertensive candesartan versus lisinopril improved neurocognitive effects in...
Continue ACE inhibitors and ARBs in reduced GFR - it has CV benefits Dr. K B Aarthi22 March 2020 5:00 PM ISTContinuing ACE-I or ARB therapy in patients with declining kidney function may be associated with the cardiovascular benefit.
